Material safety data sheet

Page 1 of 5
Section 1: Identification of the Substance and Supplier

Product name
Liquid containing 8-23% oxytetracycline hydrochloride
Recommended use
Veterinary broad-spectrum antibiotic injection for use in horses, cattle, sheep, pigs, dogs and cats. Company details
MSD Animal Health, 33 Whakatiki Street, Upper Hutt
Phone: 0800 800 543 Fax: 0800 808 100
Hours: 8 am – 5 pm, Mon – Fri

Emergency telephone
0800 764 766 (0800 POISON) 24 hours human health
0800 243 622 (0800 CHEMCALL) 24 hours

Date of preparation
Section 2: Hazards Identification

6.4A May cause eye irritation
6.5B May cause an allergic skin reaction
6.8B Suspected of damaging fertility or the unborn child from repeated oral
6.9B May cause damage to the gastrointestinal tract through prolonged or
repeated inhalation or dermal exposure at high doses.
9.1B Toxic to aquatic organisms with long lasting effects

R63 Possible risk of harm to the unborn child R51 Toxic to aquatic organisms Section 3: Composition/Information on Ingredients

Chemical name
CAS number
Section 4: First Aid Measures

Necessary first aid
ACCIDENTAL SELF-INJECTION Wash and disinfect self injection injuries.
Seek medical advice if irritancy or an allergic response occurs – show this SDS.

In case of skin contact, while wearing protective gloves,
carefully remove any contaminated clothing, including shoes, and wash skin
thoroughly with soap and water. If irritation or symptoms occur or persist, consult
a doctor.
EYE CONTACT In case of eye contact, immediately rinse eyes thoroughly with
Page 2 of 5
plenty of water. If wearing contact lenses, remove only after initial rinse, and
continue rinsing eyes for at least 15 minutes. If irritation occurs or persists,
consult a doctor.
INGESTION Rinse mouth and drink a glass of water. Do not induce vomiting
unless under the direction of a qualified medical professional or National
Poisons Centre. If symptoms persist, consult a doctor.

Remove to fresh air and provide oxygen if necessary. If any
trouble breathing, get immediate medical attention. Administer artificial
respiration if breathing has ceased. If irritation or symptoms occur or persist,
consult a doctor.
Required instructions
For advice contact the National Poisons Centre 0800 POISON (0800 764 766) Notes for medical
Accidental self-injection: Treat symptomatically. Some risk of hypersensitivity personnel
from injection. Contamination of the needle must be considered. Treat symptomatically any allergic reaction to tetracycline or any local irritancy caused by ethanolamine. Workplace facilities
Emergency showers and eyewashes may be warranted depending on quantity and type of use. Section 5: Fire Fighting Measures

Type of hazard

Fire hazard properties

Regulatory requirements

Extinguishing media
Carbon dioxide (CO2), extinguishing powder or water spray and methods
Hazchem code

Recommended protective

Wear full protective clothing and self-contained breathing apparatus (SCBA). clothing
Section 6: Accidental Release Measures

Emergency procedures
Wear chemical resistant gloves and overalls, facemask or goggles. Prevent further spillage. Adsorb spilled product and place in sealable container for disposal. Wash down affected area with water plus detergent. Absorb and collect washings and place in the same sealable container for disposal. Seek advice from the local authority regarding disposal. Avoid contamination of any water source or soil with product or empty container. SAFETY DATA SHEET
Page 3 of 5
Section 7: Handling and Storage

Precautions for safe
Avoid contact with skin, eyes, and mucosa. Keep containers adequately sealed handling
during material transfer, transport, or when not in use. See Section 8 (Exposure Regulatory requirements
Signage required where quantities greater than 1000L are present. Emergency Plan required where quantities greater than 1000L are present. Handling practices
Avoid contact with skin. Keep containers adequately sealed during material transfer, transport, or when not in use. Approved handlers
Conditions for safe
Store in original container in a cool, dry, ventilated place away from direct heat or direct sunlight. Keep container sealed when not in use. Keep out of reach of Store site requirements
Store protected from light at room temperature (8-30°C). Do not refrigerate or freeze. Packaging
Section 8: Exposure Control/Personal Protection

Workplace exposure
Ethanolamine TWA 3.0ppm (7.5mg/m3) (OSH NZ) standards

Application in the

Ensure adequate ventilation. Keep container sealed when not in use. workplace
Exposure standards

No TEL is set for this substance at this time outside the workplace
No EEL is set for this substance at this time Personal protection
Wear chemical resistant gloves, facemask or goggles. Section 9: Physical and Chemical Properties
Page 4 of 5
Section 10: Stability and Reactivity

Stability of the substance
Conditions to avoid

Material to avoid

Hazardous decomposition

May also evolve nitrogen oxides, sulphur oxides and carbon oxides when heated products
Section 11: Toxicological Information
Acute effects for individual ingredients only
Ethanolamine LD50: 620mg/kg (guinea pig) Oxytetracycline Hydrochloride LD50: 6696 mg/kg (mouse) Sodium Formaldehyde Sulphoxylate LD50 4000mg/kg (mouse) No TEL is set for this substance at this time. Chronic/long term effects for individual ingredients only
Section 12: Environmental Information
Effects for individual ingredients only.
Oxytetracycline Hydrochloride: 0.207mg/L EC50 96hr (Microcystis aeruginosa) No EEL is set for this substance at this time. Section 13: Disposal Considerations
Disposal information
Dispose of unused contents in a suitable landfill. Avoid contamination of any water source or the environment with product or empty container. Container Disposal
Dispose of empty container by puncturing and burying in a suitable landfill. Reference
Current version of NZS 8409 Management of Agrichemicals Section 14: Transport Information
Relevant information
UN3082 ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. (oxytetracycline hydrochloride) Marine Pollutant Class 9 PG III Limited quantities: 5L Maximum quantity for own agricultural use: 1000L Other requirements
Page 5 of 5
Section 15: Regulatory Information
Regulatory status
HSNO Approval Code: HSR002217.
For a full listing of controls see
ACVM registration number: A003308.
For conditions of registration see

Signage: 1000 Litres
Emergency Plan: 1000 Litres
Section 16: Other Information
Additional information
Schering-Plough Animal Health Ltd known as MSD Animal Health, is a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Schering-Plough urges each user or recipient of this SDS to read the entire data sheet to become aware of the potential hazards associated with this material. This SDS summarises, at the date of issue, our best knowledge of the health and safety hazard information. Although reasonable care has been taken in the preparation of this document, Intervet Limited extend no warranties and make no representations as to the accuracy or completeness of the information contained therein, and assume no responsibility regarding the suitability of this information for the user's intended purposes or for the consequence of its use. Each individual should make a determination as to the suitability of the information for their particular purpose(s).


Notes on the Concert Gallery Maison 44 - Ute Stoecklin On 22 November 2002 the concert gallery Maison 44 opened its doors to the public with its first exhibition and concert project. In an effort to summarize the brief history of this still-young institution, I shall draw on questions that visitors and other interested parties have posed time and again over the course of the past ten years. The


CURRICULUM VITAE DEL DOTT. EDOARDO MANNUCCI Titoli di studio 1990 Laurea in Medicina e Chirurgia (110/110 cum laude), Università di Firenze Diploma di Specializzazione in Endocrinologia (70/70 cum laude), Università di Firenze Esperienze lavorative Dirigente Medico I Livel o in Diabetologia, tempo indeterminato. Dipartimento Cuore e Vasi, SOD Cardiologia Geriatrica, Azienda

Copyright © 2011-2018 Health Abstracts